Erratum: Imaging pain in arthritis: Advances in structural and functional neuroimaging (Curr Pain Headache Rep DOI: 10.1007/s11916-012-0297-4);Imaging pain in arthritis: Advances in structural and functional neuroimaging

Current Pain and Headache Reports

Volumn 16, Issue 6, 2012, Pages 492-501

  Harvey, Ann K ^a,b   Taylor, Ann M ^a   Wise, Richard G ^a,b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Arterial spin labeling; Arthritic pain; Chronic low back pain; Chronic pain; Clinical pain; Default mode network; Experimental pain; Fibromyalgia; Functional connectivity; Functional magnetic resonance imaging; Functional neuroimaging; Osteoarthritis; Painful fluctuations; Positron emission tomography; Restingstate; Rheumatoid arthritis; Structural neuroimaging; Structural plasticity; Treatment evaluation; Voxel based morphometry

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; ANTIINFLAMMATORY ACTIVITY; ARTHRALGIA; ARTHRITIS; ARTICLE; BOLD SIGNAL; BRAIN BLOOD FLOW; BRAIN MAPPING; CLINICAL FEATURE; ELECTROENCEPHALOGRAPHY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; KNEE OSTEOARTHRITIS; LIMBIC CORTEX; MORPHOLOGY; NERVE CELL PLASTICITY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PAIN ASSESSMENT; PERFUSION WEIGHTED IMAGING; POSITRON EMISSION TOMOGRAPHY; RHEUMATOID ARTHRITIS; SPIN LABELING; THALAMUS;

EID: 84870534561     PISSN: 15313433     EISSN: 15343081     Source Type: Journal    
DOI: 10.1007/s11916-012-0302-y     Document Type: Erratum

References (65)

1. Kellgren JH, Lawrence JS. Rheumatism in miners. II. X-ray study. Br J Ind Med. 1952;9:197-207.
2. Kean WF, Kean R, Buchanan WW. Osteoarthritis: symptoms, signs and source of pain. Inflammopharmacology. 2004;12:3-31.
3. Gwilym SE, Pollard TC, Carr AJ. Understanding pain in osteoarthritis. J Bone Joint Surg Br. 2008;90:280-7.
4. Wylde V, Hewlett S, Learmonth ID, et al. Persistent pain after joint replacement: prevalence, sensory qualities, and postoperative determinants. Pain. 2011;152:566-72.
5. Moseley JB, O'Malley K, Petersen NJ, et al. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med. 2002;347:81-8.
6. Arendt-Nielsen L, Nie H, Laursen MB, et al. Sensitization in patients with painful knee osteoarthritis. Pain. 2010;149:573-81.
7. Lee MC, Zambreanu L, Menon DK, et al. Identifying brain activity specifically related to the maintenance and perceptual consequence of central sensitization in humans. J Neurosci. 2008;28:11642-9.
8. Tracey I, Mantyh PW. The cerebral signature for pain perception and its modulation. Neuron. 2007;55:377-91.
9. Schweinhardt P, Kalk N, Wartolowska K, et al. Investigation into the neural correlates of emotional augmentation of clinical pain. Neuroimage. 2008;40:759-66.
10. Gwilym SE, Keltner JR, Warnaby CE, et al. Psychophysical and functional imaging evidence supporting the presence of central sensitization in a cohort of osteoarthritis patients. Arthritis Rheum. 2009;61:1226-34. Brainstem revealed as potential mediator of central sensitisation in OA.
11. Parks EL, Geha PY, Baliki MN, et al. Brain activity for chronic knee osteoarthritis: Dissociating evoked pain from spontaneous pain. Eur J Pain 2011. Identified the targets of anti-inflammatory therapy in OA patients as the prefrontal-limbic brain areas.
12. Wartolowska K, Schweinhardt P, Wordsworth P, et al. Pain processing in rheumatoid arthritis patients successfully treated with anti-TNF. The British Society for Rheumatology. Birmingham, 2007
13. Hess A, Axmann R, Rech J, et al. Blockade of TNF-alpha rapidly inhibits pain responses in the central nervous system. Proc Natl Acad Sci U S A. 2011;108:3731-6. TNF-alpha neutralization occurs at level of brain before it acts at the joint.
14. Drewes AM, Svendsen L, Taagholt SJ, et al. Sleep in rheumatoid arthritis: a comparison with healthy subjects and studies of sleep/wake interactions. Br J Rheumatol. 1998;37:71-81.
15. Hummel T, Schiessl C, Wendler J, et al. Peripheral and central nervous changes in patients with rheumatoid arthritis in response to repetitive painful stimulation. Int J Psychophysiol. 2000;37:177-83.
16. Baliki MN, Geha PY, Apkarian AV, et al. Beyond feeling: chronic pain hurts the brain, disrupting the default-mode network dynamics. J Neurosci. 2008;28:1398-403.
17. Baliki MN, Baria AT, Apkarian AV. The cortical rhythms of chronic back pain. J Neurosci. 2011;31:13981-90. Evidence for aberrant functional connectivity in chronic back pain patients.
18. Jones AK, Derbyshire SW. Reduced cortical responses to noxious heat in patients with rheumatoid arthritis. Ann Rheum Dis. 1997;56:601-7.
19. Kulkarni B, Bentley DE, Elliott R, et al. Arthritic pain is processed in brain areas concerned with emotions and fear. Arthritis Rheum. 2007;56:1345-54.
20. Howard MA, Krause K, Khawaja N, et al. Beyond patient reported pain: perfusion magnetic resonance imaging demonstrates reproducible cerebral representation of ongoing post-surgical pain. PLoS One. 2011;6:e17096. First application of arterial spin labelling MRI to identify rCBF increases in a clinical condition.
21. Wasan AD, Loggia ML, Chen LQ, et al. Neural correlates of chronic low back pain measured by arterial spin labeling. Anesthesiology. 2011;115:364-74. Arterial spin labelling MRI identified rCBF increases in chronic back pain patients.
22. Howard MA, Sanders D, Krause K, et al. Alterations in Resting Cerebral Blood Flow Demonstrate Ongoing Pain in Osteoarthritis: An Arterial Spin Labelled Magnetic Resonance Imaging Study. Arthritis Rheum 2012; In press. The only study of arterial spin labelling in arthritis patients finds increased rCBF responses associated with on-going pain in thumb OA.
23. Rodriguez-Raecke R, Niemeier A, Ihle K, et al. Brain gray matter decrease in chronic pain is the consequence and not the cause of pain. J Neurosci. 2009;29:13746-50. Reversible brain atrophy identified 4 months after hip repalcement.
24. Gwilym SE, Filippini N, Douaud G, et al. Thalamic atrophy associated with painful osteoarthritis of the hip is reversible after arthroplasty: a longitudinal voxel-based morphometric study. Arthritis Rheum. 2010;62:2930-40. Reversible brain atrophy identified 9 months after hip replacement.
25. Ingvar M. Pain and functional imaging. Philos Trans R Soc Lond B Biol Sci. 1999;354:1347-58.
26. Apkarian AV, Bushnell MC, Treede RD, et al. Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain. 2005;9:463-84.
27. Iannetti GD, Mouraux A. From the neuromatrix to the pain matrix (and back). Exp Brain Res. 2010;205:1-12. Critical review of the evidence in favour and against the concept of pain specific neuromatrix.
28. Legrain V, Iannetti GD, Plaghki L, et al. The pain matrix reloaded: a salience detection system for the body. Prog Neurobiol. 2011;93:111-24. Proposes a cortical network that acts as a defensive system where the emphasis is no longer on the quality of the sensation elicited by noxious stimuli but on the action prompted by the occurrence of potential threats.
29. Baliki MN, Schnitzer TJ, Bauer WR, et al. Brain morphological signatures for chronic pain. PLoS One. 2011;6:e26010. Demonstrates potential for decoding condition-specific musculoskeletal pain on the basis of structural brain signatures.
30. Ploghaus A, Tracey I, Gati JS, et al. Dissociating pain from its anticipation in the human brain. Science. 1999;284:1979-81.
31. Buffington AL, Hanlon CA, McKeown MJ. Acute and persistent pain modulation of attention-related anterior cingulate fMRI activations. Pain. 2005;113:172-84.
32. Godha D, Shi L, Mavronicolas H. Association between tendency towards depression and severity of rheumatoid arthritis from a national representative sample: the Medical Expenditure Panel Survey. Curr Med Res Opin. 2010;26:1685-90.
33. Axford J, Butt A, Heron C, et al. Prevalence of anxiety and depression in osteoarthritis: use of the Hospital Anxiety and Depression Scale as a screening tool. Clin Rheumatol. 2010;29:1277-83.
34. Edwards RR, Cahalan C, Mensing G, et al. Pain, catastrophizing, and depression in the rheumatic diseases. Nat Rev Rheumatol. 2011;7:216-24.
35. Apkarian AV, Bushnell MC, Treede RD, et al. Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain. 2005;9:463-84.
36. Jensen KB, Kosek E, Petzke F, et al. Evidence of dysfunctional pain inhibition in Fibromyalgia reflected in rACC during provoked pain. Pain. 2009;144:95-100. Dysfunctional pain inhibition associated with chronic musculoskeletal disease.
37. Burgmer M, Pogatzki-Zahn E, Gaubitz M, et al. Fibromyalgia unique temporal brain activation during experimental pain: a controlled fMRI Study. J Neural Transm. 2010;117:123-31. The role of frontal cortex and PAG in contributing to central sensitisation in FMS.
38. Chen JJ, Wang JY, Chang YM, et al. Regional cerebral blood flow between primary and concomitant fibromyalgia patients: a possible way to differentiate concomitant fibromyalgia from the primary disease. Scand J Rheumatol. 2007;36:226-32.
39. Marquand A, Howard M, Brammer M, et al. Quantitative prediction of subjective pain intensity from whole-brain fMRI data using Gaussian processes. Neuroimage. 2010;49:2178-89. Presents a novel algorithmic decoding strategy for fMRI data using Gaussian processes, and extends multivariate classification tools to continuous variables.
40. Richardson EJ, Ness TJ, Doleys DM, et al. Catastrophizing, acceptance, and interference: laboratory findings, subjective report, and pain willingness as a moderator. Health Psychol. 2010;29:299-306.
41. Fox MD, Snyder AZ, Vincent JL, et al. The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc Natl Acad Sci U S A. 2005;102:9673-8.
42. Napadow V, LaCount L, Park K, et al. Intrinsic brain connectivity in fibromyalgia is associated with chronic pain intensity. Arthritis Rheum. 2010;62:2545-55. Resting-state brain activity within multiple networks associated with spontaneous clinical pain in patients with FM and subjective experiences such as pain may arise from a complex interplay among multiple brain networks.
43. Jensen KB, Loitoile R, Kosek E, et al. Patients with fibromyalgia display less functional connectivity in the Brain's pain inhibitory network. Mol Pain. 2012;8:32. Aberrant functional connectivity associated with chronic musculoskeletal disease.
44. Cauda F, Sacco K, Duca S, et al. Altered resting state in diabetic neuropathic pain. PLoS One. 2009;4:e4542.
45. Moldofsky H, Lue FA, Smythe HA. Alpha EEG sleep and morning symptoms in rheumatoid arthritis. J Rheumatol. 1983;10:373-9.
46. Derbyshire SW, Jones AK, Devani P, et al. Cerebral responses to pain in patients with atypical facial pain measured by positron emission tomography. J Neurol Neurosurg Psychiatry. 1994;57:1166-72.
47. Tracey I, Johns E. The pain matrix: reloaded or reborn as we image tonic pain using arterial spin labelling. Pain. 2010;148:359-60.
48. Owen DG, Clarke CF, Ganapathy S, et al. Using perfusion MRI to measure the dynamic changes in neural activation associated with tonic muscular pain. Pain. 2010;148:375-86. Preferential decreases in the affective component of the pain once initial anxiety dissipates.
49. Segerdahl AR, Xie J, Paterson K, et al. Imaging the neural correlates of neuropathic pain and pleasurable relief associated with inherited erythromelalgia in a single subject with quantitative arterial spin labelling. Pain. 2012;153:1122-7. Confirmed the presence of a temperature-sensitive channelopathy of peripheral neurons and the neural correlates of tonic neuropathic pain and relief in a single subject.
50. Gauthier LV, Taub E, Perkins C, et al. Remodeling the brain: plastic structural brain changes produced by different motor therapies after stroke. Stroke. 2008;39:1520-5.
51. Apkarian AV, Sosa Y, Sonty S, et al. Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J Neurosci. 2004;24:10410-5.
52. Kuchinad A, Schweinhardt P, Seminowicz DA, et al. Accelerated brain gray matter loss in fibromyalgia patients: premature aging of the brain? J Neurosci. 2007;27:4004-7.
53. Schmidt-Wilcke T, Leinisch E, Ganssbauer S, et al. Affective components and intensity of pain correlate with structural differences in gray matter in chronic back pain patients. Pain. 2006;125:89-97.
54. Schmidt-Wilcke T, Luerding R, Weigand T, et al. Striatal grey matter increase in patients suffering from fibromyalgia-A voxelbased morphometry study. Pain. 2007;132 Suppl 1:S109-16.
55. Lutz J, Jager L, de Quervain D, et al. White and gray matter abnormalities in the brain of patients with fibromyalgia: a diffusion-tensor and volumetric imaging study. Arthritis Rheum. 2008;58:3960-9.
56. May A. Chronic pain may change the structure of the brain. Pain. 2008;137:7-15.
57. Bekkelund SI, Pierre-Jerome C, Husby G, et al. Quantitative cerebral MR in rheumatoid arthritis. AJNR Am J Neuroradiol. 1995;16:767-72.
58. Wartolowska K, Hough MG, Jenkinson M, et al. Structural changes of the brain in rheumatoid arthritis. Arthritis Rheum. 2012;64:371-9. Structural atrophy of basal ganglia in patients with RA.
59. Grachev ID, Fredrickson BE, Apkarian AV. Abnormal brain chemistry in chronic back pain: an in vivo proton magnetic resonance spectroscopy study. Pain. 2000;89:7-18.
60. Harris RE, Clauw DJ. Imaging central neurochemical alterations in chronic pain with proton magnetic resonance spectroscopy. Neurosci Lett. 2012;520:192-6.
61. Luerding R, Weigand T, Bogdahn U, et al. Working memory performance is correlated with local brain morphology in the medial frontal and anterior cingulate cortex in fibromyalgia patients: structural correlates of pain-cognition interaction. Brain. 2008;131:3222-31.
62. Buckalew N, Haut MW, Morrow L, et al. Chronic pain is associated with brain volume loss in older adults: preliminary evidence. Pain Med. 2008;9:240-8.
63. Wartolowska K, Tracey I. Neuroimaging as a tool for pain diagnosis and analgesic development. Neurotherapeutics. 2009;6:755-60.
64. Wise RG, Preston C. What is the value of human FMRI in CNS drug development? Drug Discov Today. 2010;15:973-80. Review of fMRI in understanding therapeutic mechanisms and providing clinically relevant markers of disease responses to drugs to aid decision-making.
65. BalikiM, Katz J, Chialvo DR, et al. Single subject pharmacological-MRI (phMRI) study: modulation of brain activity of psoriatic arthritis pain by cyclooxygenase-2 inhibitor. Mol Pain. 2005;1:32.